These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6973349)
21. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
22. Splenic granulocytopoiesis and production of colony-stimulating activity in lymphoma and leukemia. Greenberg PL; Steed SM Blood; 1981 Jan; 57(1):119-29. PubMed ID: 6969608 [TBL] [Abstract][Full Text] [Related]
23. Biosynthesis of ferritin subunits from different cell lines of HL-60 human promyelocytic leukaemia cells and the release of acidic isoferritin-inhibitory activity against normal granulocyte-macrophage progenitor cells. Dörner MH; Broxmeyer HE; Silverstone A; Andreeff M Br J Haematol; 1983 Sep; 55(1):47-58. PubMed ID: 6576806 [TBL] [Abstract][Full Text] [Related]
24. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558 [TBL] [Abstract][Full Text] [Related]
25. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415 [TBL] [Abstract][Full Text] [Related]
26. The effect of isoferritins on granulopoiesis. Sala G; Worwood M; Jacobs A Blood; 1986 Feb; 67(2):436-43. PubMed ID: 3942830 [TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406 [TBL] [Abstract][Full Text] [Related]
28. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor. Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Estrov Z; Kurzrock R; Estey E; Wetzler M; Ferrajoli A; Harris D; Blake M; Gutterman JU; Talpaz M Blood; 1992 Apr; 79(8):1938-45. PubMed ID: 1373331 [TBL] [Abstract][Full Text] [Related]
30. Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins. Lu L; Broxmeyer HE; Meyers PA; Moore MA; Thaler HT Blood; 1983 Feb; 61(2):250-6. PubMed ID: 6185165 [TBL] [Abstract][Full Text] [Related]
31. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells. Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394 [TBL] [Abstract][Full Text] [Related]
32. The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitors. Estrov Z; Park CH; Reading CL; Estey EH; Talpaz M; Kurzrock R; Deisseroth AB; Gutterman JU Exp Hematol; 1992 Aug; 20(7):886-90. PubMed ID: 1628706 [TBL] [Abstract][Full Text] [Related]
33. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [TBL] [Abstract][Full Text] [Related]
34. Leukemia-associated inhibitory activity in acute leukemia developed from myelodysplastic syndrome. Fukuoka T; Fujita S Jpn J Med; 1987 Aug; 26(3):314-8. PubMed ID: 3501031 [TBL] [Abstract][Full Text] [Related]
35. Biochemical and immunological characteristics of ferritin from HL-60, U-937 and K-562 cell lines: implications for haemopoietic regulation. Wyllie F; Jacobs A; Waradanukul K; Worwood M; Wagstaff M Leuk Res; 1984; 8(6):1095-101. PubMed ID: 6546290 [TBL] [Abstract][Full Text] [Related]
36. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3. Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286 [TBL] [Abstract][Full Text] [Related]
37. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors. Sarris AH; Talpaz M; Deisseroth AB; Estrov Z Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668 [TBL] [Abstract][Full Text] [Related]
38. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia. Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha. Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937 [TBL] [Abstract][Full Text] [Related]
40. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]